Department of Biophysics and Nuclear Medicine, Bicêtre University Hospital, Assistance Publique-Hôpitaux de Paris, 94275, Le Kremlin-Bicêtre, France.
Department of Internal Medicine, Bicêtre University Hospital, Assistance Publique-Hôpitaux de Paris, 94275, Le Kremlin-Bicêtre, France.
Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):575-581. doi: 10.1007/s00259-017-3798-x. Epub 2017 Aug 30.
The aim of this study was to quantify the association between the CRP value and F-FDG PET vascular positivity in Takayasu arteritis (TAK) through a structured dedicated systematic review and meta-analysis.
From January 2000 to December 2016, the PubMed/MEDLINE database was searched for articles specifically dealing with the assessment of vascular inflammation using F-FDG PET and CRP biomarkers in TAK. Inclusion criteria for the qualitative analysis were (1) F-FDG PET used to assess the disease activity, (2) The use of the ACR criteria for the diagnosis of TAK, (3) No case mixed vasculitis (i.e., no giant cell arteritis), and (4) CRP concentration and clinical disease activity available. For the meta-analysis, PET-positive and PET-negative subgroups with the corresponding CRP concentrations were generated based on per patient data. The standard mean difference, which represents the effect of the CRP concentrations on the F-FDG PET vascular uptake, was computed for all studies, and then the results were pooled together.
Among the 33 initial citations, nine complete articles including 210 patients fulfilled the inclusion criteria. Five studies found a significant correlation between the F-FDG PET and CRP concentration, one provided a trend towards association and three did not find any association between the two biomarkers. Six studies found a significant association between F-FDG PET and clinical disease activity, one found a trend towards association and the last two studies did not evaluate this correlation. The meta-analysis (121 patients) provided the following results: Standard Mean Deviation = 0.54 [0.15;0.92]; Chi = 3.35; I = 0%; Test for overall effect: Z = 2.70 (P = 0.007).
The CRP concentration only moderately reflects the F-FDG PET vascular positivity in TAK, suggesting dissociated information. Standardized longitudinal prospective studies are necessary to assess the value of F-FDG PET as an independent biomarker for subtle vascular wall inflammation detection.
本研究旨在通过系统评价和荟萃分析,定量评估 C 反应蛋白(CRP)值与 Takayasu 动脉炎(TAK)中 F-FDG PET 血管阳性之间的相关性。
从 2000 年 1 月至 2016 年 12 月,检索了专门使用 F-FDG PET 和 CRP 生物标志物评估 TAK 血管炎症的文章,检索数据库为 PubMed/MEDLINE。定性分析的纳入标准为:(1)使用 F-FDG PET 评估疾病活动度,(2)采用 ACR 标准诊断 TAK,(3)不混合血管炎病例(即无巨细胞动脉炎),(4)CRP 浓度和临床疾病活动度可用。对于荟萃分析,根据每位患者的数据生成 PET 阳性和 PET 阴性亚组,以及相应的 CRP 浓度。计算所有研究的标准均数差(代表 CRP 浓度对 F-FDG PET 血管摄取的影响),然后将结果汇总在一起。
在 33 篇初始引用文章中,有 9 篇完整的文章,共 210 例患者符合纳入标准。五项研究发现 F-FDG PET 与 CRP 浓度之间存在显著相关性,一项研究发现两者之间存在相关性趋势,而另外三项研究未发现这两种生物标志物之间存在任何关联。六项研究发现 F-FDG PET 与临床疾病活动之间存在显著相关性,一项研究发现两者之间存在相关性趋势,而另外两项研究未评估这一相关性。荟萃分析(121 例患者)的结果为:标准均数差=0.54[0.15;0.92];卡方值=3.35;I²=0%;总效应检验:Z 值=2.70(P=0.007)。
CRP 浓度仅能适度反映 TAK 中 F-FDG PET 血管阳性,表明两者信息不相关。需要进行标准化的纵向前瞻性研究,以评估 F-FDG PET 作为检测细微血管壁炎症的独立生物标志物的价值。